Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT

Severe combined immunodeficiency (SCID) is effectively treated with hematopoietic cell transplantation (HCT), with overall survival approaching 90% in contemporary reports. However, survivors are at risk for developing late complications because of the variable durability of high-quality immune func...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Heimall, Jennifer, Buckley, Rebecca H., Puck, Jennifer, Fleisher, Thomas A., Gennery, Andrew R., Haddad, Elie, Neven, Benedicte, Slatter, Mary, Roderick, Skinner, Baker, K. Scott, Dietz, Andrew C., Duncan, Christine, Griffith, Linda M., Notarangelo, Luigi, Pulsipher, Michael A., Cowan, Morton J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015789/
https://ncbi.nlm.nih.gov/pubmed/28479164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados